Search results
Results From The WOW.Com Content Network
If you put $10,000 into Bristol Myers stock 10 years ago, it would be worth less than $8,800 today, versus nearly $27,800 if you just invested in the broad index.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. ... in terms of its price-to-sales ratio, should provide a layer of downside protection. ... The Today Show.
Key recent clinical pipeline developments have prompted an analyst at Truist Securities to turn bullish on pharma giant Bristol-Myers Squibb Company (NYSE: BMY). The Bristol-Myers Squibb Analyst ...
3. Bristol Myers Squibb. Shares of Bristol Myers Squibb (NYSE: BMY) have dropped by about 50% from the peak they reached in late 2022. At its beaten-down price, the pharma stock offers a 5.9% ...
Beech-Nut's roots go back to 1891, to the Mohawk Valley town of Canajoharie, New York. Raymond P. Lipe, along with his friend John D. Zieley and their brothers, Walter H. Lipe and David Zieley, and Bartlett Arkell, founded The Imperial Packing Co. for the production of Beech-Nut ham. The product was based on the smoked hams of the Lipes' father ...
Number of employees. 600 (2022) Parent. Bristol Myers Squibb. Website. mirati .com. Mirati Therapeutics, Inc. is an American targeted oncology company that focuses on the development of cancer therapeutics. [1] Bristol Myers Squibb acquired the company in January 2024. [2]
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day. This change was narrower than the S&P 500's 3.39% loss on the day.